BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
US Department of Justice
Cipla
Medtronic
Cerilliant
Harvard Business School
Teva
Argus Health
Citi
Novartis

Generated: January 16, 2018

DrugPatentWatch Database Preview

AMINOSYN II 10% Drug Profile

« Back to Dashboard

When do Aminosyn Ii 10% patents expire, and when can generic versions of Aminosyn Ii 10% launch?

Aminosyn Ii 10% is a drug marketed by Icu Medical Inc and is included in three NDAs.

The generic ingredient in AMINOSYN II 10% is amino acids; magnesium chloride; potassium chloride; potassium phosphate, dibasic; sodium chloride. There are three hundred and forty-one drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amino acids; magnesium chloride; potassium chloride; potassium phosphate, dibasic; sodium chloride profile page.
Summary for AMINOSYN II 10%
Drug patent expirations by year for AMINOSYN II 10%
Pharmacology for AMINOSYN II 10%
Ingredient-typeAmino Acids
Drug ClassAmino Acid

US Patents and Regulatory Information for AMINOSYN II 10%

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Icu Medical Inc AMINOSYN II 10% amino acids INJECTABLE;INJECTION 019438-005 Apr 3, 1986 RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Icu Medical Inc AMINOSYN II 10% IN PLASTIC CONTAINER amino acids INJECTABLE;INJECTION 020015-001 Dec 19, 1991 RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Icu Medical Inc AMINOSYN II 10% W/ ELECTROLYTES amino acids; magnesium chloride; potassium chloride; potassium phosphate, dibasic; sodium chloride INJECTABLE;INJECTION 019437-004 Apr 3, 1986 RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
McKinsey
Chubb
Medtronic
Daiichi Sankyo
Healthtrust
US Army
Moodys
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot